Preclinical Evaluation of Fingolimod in Rodent Models of Stroke With Age or Atherosclerosis as Comorbidities

Overview of attention for article published in Frontiers in Pharmacology, July 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 9,793 followers.

RT @BetterOffMalone: Our latest research investigating fingolimod as a treatment for stroke is now published. For this work, @andreadiaz46…

15 Jul 2022

Reply Repost Favourite

RT @BetterOffMalone: Our latest research investigating fingolimod as a treatment for stroke is now published. For this work, @andreadiaz46…

14 Jul 2022

Reply Repost Favourite

RT @BetterOffMalone: Our latest research investigating fingolimod as a treatment for stroke is now published. For this work, @andreadiaz46…

14 Jul 2022

Reply Repost Favourite

Our latest research investigating fingolimod as a treatment for stroke is now published. For this work, @andreadiaz46 looked at multiple doses of FTY720, various treatment durations, and age/atherosclerosis as comorbidities. Exciting stuff! https://t.co/5

13 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.